1. Non-Fatal Strangulation Laws and Intimate Partner Homicides. (2025). de Assis, Drcio ; Ghosh, Arpita ; Oreffice, Sonia ; Quintana-Domeque, Climent.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp18006.

   Full description at Econpapers || Download paper

2. Non-Fatal Strangulation Laws and Intimate Partner Homicides. (2025). Oreffice, Sonia ; Ghosh, Arpita ; de Assis, Drcio ; Quintana-Domeque, Climent.
   In: Discussion Papers.
   RePEc:exe:wpaper:2501.

   Full description at Econpapers || Download paper

3. Using Policy and Innovation to Improve Life-Saving Access to Naloxone. (2024). Powell, David ; Pacula, Rosalie ; Peet, Evan D.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:33105.

   Full description at Econpapers || Download paper

1. Abbas, B. ; Marotta, P.L. ; Goddard-Eckrich, D. ; Huang, D. ; Schnaidt, J. ; El-Bassel, N. ; Gilbert, L. Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City. 2021 Drug Alcohol Depend.. 218 -
   Paper not yet in RePEc: Add citation now
   
2. Abouk, R. ; Helmchen, L. ; Moghtaderi, A. ; Pines, J. The ACA medicaid expansions and opioid mortality: is there a link?. 2021 Med. Care Res. Rev.. 78 713-724
   Paper not yet in RePEc: Add citation now
   
3. Abouk, R. ; Pacula, R.L. ; Powell, D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. 2019 JAMA Intern. Med.. 179 805-811
   Paper not yet in RePEc: Add citation now
   

4. Alpert, A. ; Powell, D. ; Pacula, R.L. Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids. 2018 Am. Econ. J. - Econ. Policy. 10 1-35

5. Altekruse, S.F. ; Cosgrove, C.M. ; Altekruse, W.C. ; Jenkins, R.A. ; Blanco, C. Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the mortality disparities in American Communities Study (MDAC). 2020 PLoS One. 15 -

6. Beletsky, L. ; Ruthazer, R. ; Macalino, G.E. ; Rich, J.D. ; Tan, L. ; Burris, S. Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. 2007 J. Urban Health. 84 126-136
   Paper not yet in RePEc: Add citation now
   
7. Berenbrok, L.A. ; Tang, S. ; Gabriel, N. ; Guo, J. ; Sharareh, N. ; Patel, N. ; Dickson, S. ; Hernandez, I. Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis. 2022 J. Am. Pharm. Assoc.. 62 1816-1822
   Paper not yet in RePEc: Add citation now
   

8. Borusyak, K. ; Jaravel, X. ; Spiess, J. Revisiting event study designs: robust and efficient estimation. 2024 Rev. Econ. Stud.. rdae007-

9. Brewer, M. ; Crossley, T.F. ; Joyce, R. Inference with difference-in-differences revisited. 2018 J. Econom. Methods. 7 -

10. Burris, S. ; Norland, J. ; Edlin, B.R. Legal aspects of providing naloxone to heroin users in the United States. 2001 Int. J. Drug Policy. 12 237-248
    Paper not yet in RePEc: Add citation now
    
11. Butts, K. (2023). Did2s: Stata module to estimate a TWFE model using the two-stage difference-in-differences approach.
    Paper not yet in RePEc: Add citation now
    
12. Caetano, C., Callaway, B., Payne, S., & Rodrigues, H.S.A. (2022). Difference in differences with time-varying covariates. arXiv preprintarXiv:2202.02903.
    Paper not yet in RePEc: Add citation now
    
13. Carpenter, D.M. ; Roberts, C.A. ; Westrick, S.C. ; Ferreri, S.P. ; Kennelty, K.A. ; Look, K.A. ; Abraham, O. ; Wilson, C. A content review of online naloxone continuing education courses for pharmacists in states with standing orders. 2018 Res. Soc. Adm. Pharm.. 14 968-978
    Paper not yet in RePEc: Add citation now
    
14. Cataife, G. ; Dong, J. ; Davis, C.S. Regional and temporal effects of naloxone access laws on opioid overdose mortality. 2021 Subst. Abus.. 42 329-338
    Paper not yet in RePEc: Add citation now
    

15. Cawley, J., & Dragone, D. (2023). Harm reduction: when does it improve health, and when does it backfire? Working paper 30926. National Bureau of Economic Research.

16. Centers for Disease Control and Prevention. (2019). Still not enough naloxone where it's most needed.https://www.cdc.gov/media/releases/2019/p0806-naloxone.html.
    Paper not yet in RePEc: Add citation now
    
17. Cerdá, M. ; Wheeler-Martin, K. ; Bruzelius, E. ; Ponicki, W. ; Gruenewald, P. ; Mauro, C. ; Crystal, S. ; Davis, C.S. ; Keyes, K. ; Hasin, D. Spatiotemporal analysis of the association between pain management clinic laws and opioid prescribing and overdose deaths. 2021 Am. J. Epidemiol.. 190 2592-2603
    Paper not yet in RePEc: Add citation now
    
18. Chamberlain, J.A. ; Klein, B.L. A comprehensive review of naloxone for the emergency physician. 1994 Am. J. Emerg. Med.. 12 650-660
    Paper not yet in RePEc: Add citation now
    
19. Clark, A.K. ; Wilder, C.M. ; Winstanley, E.L. A systematic review of community opioid overdose prevention and naloxone distribution programs. 2014 J. Addict. Med.. 8 153-163
    Paper not yet in RePEc: Add citation now
    

20. Currie, J.C., & Schwandt, H. (2020). The opioid epidemic was not caused by economic distress but by factors that could be more rapidly addressed. Working paper 27544. National Bureau of Economic Research. https://www.nber.org/system/files/working_papers/w27544/w27544.pdf.

21. Davis, C.S. ; Carr, D. Legal changes to increase access to naloxone for opioid overdose reversal in the United States. 2015 Drug Alcohol Depend.. 157 112-120
    Paper not yet in RePEc: Add citation now
    
22. Davis, C.S. ; Carr, D. State legal innovations to encourage naloxone dispensing. 2017 J. Am. Pharm. Assoc.. 57 S180-S184
    Paper not yet in RePEc: Add citation now
    
23. Davis, C.S. ; Lieberman, A.J. Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019. 2021 Addiction. 116 1817-1827
    Paper not yet in RePEc: Add citation now
    

24. De Chaisemartin, C. ; D’haultfœuille, X. Two-way fixed effects and differences-in-differences estimators with several treatments. 2023 J. Econom.. 236 -

25. Doleac, J.L. ; Mukherjee, A. The effects of naloxone access laws on opioid abuse, mortality, and crime. 2022 J. Law Econ.. 65 211-238

26. Eldridge, L.A. ; Agley, J. ; Meyerson, B.E. Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order. 2020 J. Am. Pharm. Assoc.. 60 470-474
    Paper not yet in RePEc: Add citation now
    

27. Erfanian, E. ; Grossman, D. ; Collins, A.R. The impact of naloxone access laws on opioid overdose deaths in the US. 2019 Rev. Reg. Stud.. 49 45-72

28. Evoy, K.E. ; Hill, L.G. ; Groff, L. ; Mazin, L. ; Carlson, C.C. ; Reveles, K.R. Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas. 2018 JAMA. 320 1934-1937
    Paper not yet in RePEc: Add citation now
    

29. Gardner, J. (2022). Two-stage differences in differences. arXiv preprintarXiv:2207.05943.

30. Gertner, A.K. ; Domino, M.E. ; Davis, C.S. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from medicaid. 2018 Drug Alcohol Depend.. 190 37-41
    Paper not yet in RePEc: Add citation now
    

31. Goodman-Bacon, A. Difference-in-differences with variation in treatment timing. 2021 J. Econom.. 225 254-277

32. Graves, R.L. ; Andreyeva, E. ; Perrone, J. ; Shofer, F. ; Merchant, R.M. ; Meisel, Z.F. Naloxone availability and pharmacy staff knowledge of standing order for naloxone in Pennsylvania pharmacies. 2019 J. Addict. Med.. 13 272-
    Paper not yet in RePEc: Add citation now
    
33. Green, T.C. ; Dauria, E.F. ; Bratberg, J. ; Davis, C.S. ; Walley, A.Y. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. 2015 Harm. Reduct. J.. 12 1-9
    Paper not yet in RePEc: Add citation now
    
34. Green, T.C. ; Davis, C. ; Xuan, Z. ; Walley, A.Y. ; Bratberg, J. Laws mandating coprescription of naloxone and their impact on naloxone prescription in five US states, 2014–2018. 2020 Am. J. Public Health. 110 881-887
    Paper not yet in RePEc: Add citation now
    
35. Guy, G.P. ; Haegerich, T.M. ; Evans, M.E. ; Losby, J.L. ; Young, R. ; Jones, C.M Vital signs: pharmacy-based naloxone dispensing—United States, 2012–2018. 2019 Morb. Mortal. Wkly. Rep.. 68 679-
    Paper not yet in RePEc: Add citation now
    

36. Hansen, L.P. Large sample properties of generalized method of moments estimators. 1982 Econometrica. 50 1029-1054

37. Hill, L.G. ; Reveles, K.R. ; Evoy, K.E. State-level approaches to expanding pharmacists’ authority to dispense naloxone may affect accessibility. 2019 JAMA Intern. Med.. 179 1442-1443
    Paper not yet in RePEc: Add citation now
    
38. Hilts, K.E. ; Corelli, R.L. ; Vernon, V.P. ; Hudmon, K.S. Update and recommendations: pharmacists’ prescriptive authority for tobacco cessation medications in the United States. 2022 J. Am. Pharm. Assoc.. 62 1531-1537
    Paper not yet in RePEc: Add citation now
    
39. HRSA (2024). Scoring Shortage Designations. https://bhw.hrsa.gov/workforce-shortage-areas/shortage-designation/scoring, last accessed April 11, 2024.
    Paper not yet in RePEc: Add citation now
    
40. Irvine, M.A. ; Oller, D. ; Boggis, J. ; Bishop, B. ; Coombs, D. ; Wheeler, E. ; Doe-Simkins, M. ; Walley, A.Y. ; Marshall, B.D.L. ; Bratberg, J. ; Green, T.C. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. 2022 Lancet Public Health. 7 e210-e218
    Paper not yet in RePEc: Add citation now
    

41. Jacobson, M. ; Powell, D. Price sensitivity and information barriers to the take-up of naloxone. 2024 Am. Econ. J.. 16 -

42. Kuo, Y.-F. ; Raji, M.A. ; Goodwin, J.S. Association of disability with mortality from opioid overdose among US Medicare adults. 2019 JAMA Netw. Open. 2 -
    Paper not yet in RePEc: Add citation now
    
43. Lee, B. ; Zhao, W. ; Yang, K.C. ; Ahn, Y.Y. ; Perry, B.L. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007–2018. 2021 JAMa Netw. Open. 4 -
    Paper not yet in RePEc: Add citation now
    
44. Lindner, S.R. ; Hart, K. ; Manibusan, B. ; McCarty, D. ; McConnell, K.J. State-and county-level geographic variation in opioid use disorder, medication treatment, and opioid-related overdose among medicaid enrollees. 2023 JAMA Health Forum. 4 -
    Paper not yet in RePEc: Add citation now
    
45. Lott, B.E. ; Anderson, E.J. ; Villa Zapata, L. ; Cooley, J. ; Forbes, S. ; Taylor, A.M. ; Manygoats, T. ; Warholak, T. Expanding pharmacists’ roles: pharmacists’ perspectives on barriers and facilitators to collaborative practice. 2021 J. Am. Pharm. Assoc.. 61 213-220
    Paper not yet in RePEc: Add citation now
    
46. McClellan, C. ; Lambdin, B.H. ; Ali, M.M. ; Mutter, R. ; Davis, C.S. ; Wheeler, E. ; Pemberton, M. ; Kral, A.H. Opioid-overdose laws association with opioid use and overdose mortality. 2018 Addict. Behav.. 86 90-95
    Paper not yet in RePEc: Add citation now
    
47. Meyerson, B.E. ; Agley, J.D. ; Davis, A. ; Jayawardene, W. ; Hoss, A. ; Shannon, D.J. ; Ryder, P.T. ; Ritchie, K. ; Gassman, R. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. 2018 Drug Alcohol Depend.. 188 187-192
    Paper not yet in RePEc: Add citation now
    
48. Mizushima, Y., Powell, D., Abouk, R., & Damberg, C. (2024). Regulating quasi-legal markets: evidence from pain management clinic laws. Available at SSRN 4704757.
    Paper not yet in RePEc: Add citation now
    
49. Mozingo, A.M. Maine moves toward increasing access to naloxone: bill would allow anyone to get overdose reversal drug. 2018 Seacostonline. -
    Paper not yet in RePEc: Add citation now
    
50. National Center for Health Statistics. (2021). Vintage 2020 postcensal estimates of the resident population of the United States (April 1, 2010, July 1, 2010–July 1, 2020), by year, county, single-year of age (0, 1, 2, 85 years and over), bridged race, Hispanic origin, and sex. Prepared under a collaborative arrangement with the U.S. Census Bureau. Available from: /nchs/nvss/bridged_race.htm as of September 22, 2021, following release by the U.S. Census Bureau of the unbridged Vintage 2020 postcensal estimates by 5-year age group on June 17, 2021.
    Paper not yet in RePEc: Add citation now
    
51. Opioid Policy Tools and Information Center (OPTIC). (2022). RAND-USC Schaeffer OPTIC Policy Data. Obtained from https://www.rand.org/health-care/centers/optic/resources/datasets.html on November 30, 2022.
    Paper not yet in RePEc: Add citation now
    
52. Peet, E.D. ; Powell, D. ; Pacula, R.L. Trends in out-of-pocket costs for naloxone by drug brand and payer in the US, 2010-2018. 2022 JAMA Health Forum. 3 -
    Paper not yet in RePEc: Add citation now
    

53. Powell, D. ; Pacula, R.L. The evolving consequences of Oxycontin reformulation on drug overdoses. 2021 Am. J. Health Econ.. 7 41-67

54. Powell, D. (2023). The labor supply consequences of the opioid crisis. RAND Working Paper. https://www.rand.org/content/dam/rand/pubs/working_papers/WRA1400/WRA1484-1/RAND_WRA1484-1.pdf.
    Paper not yet in RePEc: Add citation now
    
55. Qato, D.M. ; Alexander, G.C. ; Guadamuz, J.S. ; Choi, S. ; Trotzky-Sirr, R. ; Lindau, S.T. Pharmacist-prescribed and over-the-counter hormonal contraception in Los Angeles County retail pharmacies. 2020 Health Aff.. 39 1219-1228
    Paper not yet in RePEc: Add citation now
    

56. Rees, D.I. ; Sabia, J.J. ; Argys, L.M. ; Dave, D. ; Latshaw, J. With a little help from my friends: the effects of Good Samaritan and naloxone access laws on opioid-related deaths. 2019 J. Law Econ.. 62 1-27

57. Roberts, A.W. ; Carpenter, D.M. ; Smith, A. ; Look, K.A. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists. 2019 Res. Soc. Adm. Pharm.. 15 222-225
    Paper not yet in RePEc: Add citation now
    
58. Rodriguez, M.I. ; Edelman, A.B. ; Skye, M. ; Anderson, L. ; Darney, B.G. Association of pharmacist prescription with dispensed duration of hormonal contraception. 2020 JAMA Netw. Open. 3 -
    Paper not yet in RePEc: Add citation now
    
59. Rudolph, K.E. ; Gimbrone, C. ; Matthay, E.C. ; Díaz, I. ; Davis, C.S. ; Keyes, K. ; Cerdá, M. When effects cannot be estimated: redefining estimands to understand the effects of naloxone access laws. 2022 Epidemiology. 33 689-698
    Paper not yet in RePEc: Add citation now
    
60. Sachdev, G. ; Kliethermes, M.A. ; Vernon, V. ; Leal, S. ; Crabtree, G. Current status of prescriptive authority by pharmacists in the United States. 2020 J. Am. Coll. Clin. Pharm.. 3 807-817
    Paper not yet in RePEc: Add citation now
    
61. Santa, H.M. ; Amirova, S.G. ; Ventricelli, D.J. ; Downs, G.E. ; Nowalk, A.A. ; Pringle, J.L. ; Aruru, M. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order. 2021 Am. J. Health - Syst. Pharm.. 78 327-335
    Paper not yet in RePEc: Add citation now
    
62. Smart, R. ; Geiger, C.K. ; Jones, C.M. ; Stein, B.D. An observational study of retail pharmacy naloxone prescriptions: differences across provider specialties and patient populations. 2020 J. Gen. Intern. Med.. 35 1768-1775
    Paper not yet in RePEc: Add citation now
    
63. Smart, R. ; Haffajee, R.L. ; Davis, C.S. Legal review of state emergency medical services policies and protocols for naloxone administration. 2022 Drug Alcohol Depend.. 238 -
    Paper not yet in RePEc: Add citation now
    
64. Smart, R. ; Pardo, B. ; Davis, C.S. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. 2021 Addiction. 116 6-17
    Paper not yet in RePEc: Add citation now
    
65. Sohn, M. ; Talbert, J.C. ; Huang, Z. ; Lofwall, M.R. ; Freeman, P.R. Association of naloxone coprescription laws with naloxone prescription dispensing in the United States. 2019 JAMA Netw. Open. 2 -
    Paper not yet in RePEc: Add citation now
    
66. Spivey, C.A. ; Wilder, A. ; Chisholm-Burns, M.A. ; Stallworth, S. ; Wheeler, J. Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies. 2020 J. Am. Pharm. Assoc.. 60 694-701
    Paper not yet in RePEc: Add citation now
    

67. Streeter, R.A. ; Snyder, J.E. ; Kepley, H. ; Stahl, A.L. ; Li, T. ; Washko, M.M. The geographic alignment of primary care Health Professional Shortage Areas with markers for social determinants of health. 2020 PLoS One. 15 -

68. Sun, L. ; Abraham, S. Estimating dynamic treatment effects in event studies with heterogeneous treatment effects. 2021 J. Econom.. 225 175-199

69. Tanz, L.J. Routes of drug use among drug overdose deaths—United States, 2020–2022. 2024 MMWR Morb. Mortal. Wkly. Rep.. 73 124-130
    Paper not yet in RePEc: Add citation now
    
70. Thakur, T. ; Frey, M. ; Chewning, B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: a systematic review. 2020 J. Am. Pharm. Assoc.. 60 178-194
    Paper not yet in RePEc: Add citation now
    
71. Tormohlen, K.N. ; Schmid, I. ; Stuart, E.A. ; Davis, C. ; McGinty, E.E. State laws that require coprescribing opioids and naloxone and codispensing practices. 2024 Am. J. Prev. Med.. 66 138-145
    Paper not yet in RePEc: Add citation now
    
72. Townsend, T. ; Blostein, F. ; Doan, T. ; Madson-Olson, S. ; Galecki, P. ; Hutton, D.W. Cost-effectiveness analysis of alternative naloxone distribution strategies: first responder and lay distribution in the United States. 2020 Int. J. Drug Policy. 75 -
    Paper not yet in RePEc: Add citation now
    
73. Wheeler, E. ; Jones, T.S. ; Gilbert, M.K. ; Davidson, P.J. Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. 2015 Morb. Mortal. Wkly. Rep.. 64 631-
    Paper not yet in RePEc: Add citation now
    
74. Xu, J. ; Davis, C.S. ; Cruz, M. ; Lurie, P. State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. 2018 Drug Alcohol Depend.. 189 37-41
    Paper not yet in RePEc: Add citation now
    
75. Xu, J. ; Mukherjee, S. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies. 2021 Drug Alcohol Depend.. 227 -
    Paper not yet in RePEc: Add citation now
    

1. Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare. (2023). Simon, Kosali ; Maclean, Johanna ; Cantor, Jonathan H ; Taylor, Erin ; Agniel, Denis.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:31884.

   Full description at Econpapers || Download paper

2. Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior. (2022). Grooms, Jevay ; Ellyson, Alice M ; Ortega, Alberto.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341.

   Full description at Econpapers || Download paper

3. Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21. (2022). Mulligan, Casey.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:29719.

   Full description at Econpapers || Download paper

4. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp15221.

   Full description at Econpapers || Download paper

5. Opioids and the Labor Market. (2022). Schweitzer, Mark ; Fee, Kyle ; Aliprantis, Dionissi.
   In: Working Papers.
   RePEc:fip:fedcwq:180702.

   Full description at Econpapers || Download paper

6. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: CESifo Working Paper Series.
   RePEc:ces:ceswps:_9704.

   Full description at Econpapers || Download paper

7. Are prescription drug monitoring laws effective for all? Evidence from administrative data. (2022). Gupta, Sumedha ; al Achkar, Morhaf ; Ray, Bradley.
   In: Contemporary Economic Policy.
   RePEc:bla:coecpo:v:40:y:2022:i:1:p:28-47.

   Full description at Econpapers || Download paper

8. Information Avoidance and Celebrity Exposure: The Effect of Magic Johnson on AIDS Diagnoses and Mortality in the U.S.. (2021). Martin, Joshua ; Rodriguez, Zachary ; Cardazzi, Alexander.
   In: Working Papers.
   RePEc:wvu:wpaper:21-04.

   Full description at Econpapers || Download paper

9. Prescription drug monitoring programs, opioid abuse, and crime. (2021). Horn, Brady ; Deza, Monica ; Dave, Dhaval.
   In: Southern Economic Journal.
   RePEc:wly:soecon:v:87:y:2021:i:3:p:808-848.

   Full description at Econpapers || Download paper

10. The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity. (2021). Wang, Lucy Xiaolu.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:9:p:2026-2046.

    Full description at Econpapers || Download paper

11. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

12. Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation. (2021). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29574.

    Full description at Econpapers || Download paper

13. Illicit Drugs and the Decline of the Middle Class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14035.

    Full description at Econpapers || Download paper

14. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

15. Thinking outside the box: The cross-border effect of tax cuts on R&D. (2021). Schwab, Thomas ; Todtenhaupt, Maximilian.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:204:y:2021:i:c:s0047272721001729.

    Full description at Econpapers || Download paper

16. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

17. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. (2021). Hollingsworth, Alex ; Nguyen, Thuy ; Simon, Kosali ; Sacks, Daniel W.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629620310432.

    Full description at Econpapers || Download paper

18. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. (2021). Kim, Bo Kyung.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:75:y:2021:i:c:s0167629620310547.

    Full description at Econpapers || Download paper

19. Illicit drugs and the decline of the middle class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:183:y:2021:i:c:p:718-743.

    Full description at Econpapers || Download paper

20. Designing interagency responses to wicked problems: Creating a common, cross-agency understanding. (2021). Sydelko, Pamela ; Midgley, Gerald ; Espinosa, Angela.
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:294:y:2021:i:1:p:250-263.

    Full description at Econpapers || Download paper

21. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

22. The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime. (2021). Giua, Ludovica ; Ludovica, Giua ; Claudio, Deiana.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:21:y:2021:i:2:p:751-792:n:11.

    Full description at Econpapers || Download paper

23. Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses. (2021). d'Este, Rocco.
    In: Economica.
    RePEc:bla:econom:v:88:y:2021:i:349:p:208-233.

    Full description at Econpapers || Download paper

24. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

25. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. (2020). Buchmueller, Thomas C ; Meille, Giacomo ; Carey, Colleen M.
    In: Health Economics.
    RePEc:wly:hlthec:v:29:y:2020:i:9:p:957-974.

    Full description at Econpapers || Download paper

26. Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucn:wpaper:202025.

    Full description at Econpapers || Download paper

27. Drugs on the Web, Crime in the Streets. The impact of Dark Web marketplaces on street crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucd:wpaper:202009.

    Full description at Econpapers || Download paper

28. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

29. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. (2020). Simon, Kosali ; Gupta, Sumedha ; Nguyen, Thuy D ; Freeman, Patricia R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27520.

    Full description at Econpapers || Download paper

30. Three Myths about Federal Regulation. (2020). Mulligan, Casey ; McLaughlin, Patrick A.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27233.

    Full description at Econpapers || Download paper

31. Paid sick-leave and physical mobility: Evidence from the United States during a pandemic. (2020). Simon, Kosali ; Pesko, Michael ; Maclean, Johanna ; Andersen, Martin.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27138.

    Full description at Econpapers || Download paper

32. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

33. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26812.

    Full description at Econpapers || Download paper

34. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2020-10.

    Full description at Econpapers || Download paper

35. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13395.

    Full description at Econpapers || Download paper

36. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

37. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

38. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

39. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. (2020). Powell, David ; Pacula, Rosalie ; Taylor, Erin.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303029.

    Full description at Econpapers || Download paper

40. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey B.
    In: Working Papers.
    RePEc:bfi:wpaper:2020-10.

    Full description at Econpapers || Download paper

41. Shackling the Identification Police?. (2019). Ruhm, Christopher.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:85:y:2019:i:4:p:1016-1026.

    Full description at Econpapers || Download paper

42. Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. (2019). Wettstein, Gal.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:5:p:666-677.

    Full description at Econpapers || Download paper

43. Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin. (2019). Beheshti, David.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:12:p:1449-1461.

    Full description at Econpapers || Download paper

44. How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs. (2019). Simon, Kosali ; Bradford, W. David ; Nguyen, Thuy D.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26356.

    Full description at Econpapers || Download paper

45. Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. (2019). Simon, Kosali ; Hollingsworth, Alex ; Nguyen, Thuy D ; Sacks, Daniel W.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25974.

    Full description at Econpapers || Download paper

46. A novel supply-side measure to combat abuse of addictive prescription drugs. (2019). Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2019_11.

    Full description at Econpapers || Download paper

47. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Bockerman, Petri ; Saxell, Tanja.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12275.

    Full description at Econpapers || Download paper

48. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Saxell, Tanja ; Bockerman, Petri.
    In: Working Papers.
    RePEc:fer:wpaper:117.

    Full description at Econpapers || Download paper

49. Drivers of the fatal drug epidemic. (2019). Ruhm, Christopher.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:64:y:2019:i:c:p:25-42.

    Full description at Econpapers || Download paper

50. Shackling the Identification Police?. (2018). Ruhm, Christopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25320.

    Full description at Econpapers || Download paper

Report date: 2025-09-29 14:17:44 || Missing content? Let us know